IP Library Granted Patent US 10,508,304
Granted Patent B2
US 10,508,304 · App. 15/338,560 · Granted Dec 17, 2019

High throughput genome-wide translocation sequencing

Inventors: Frederick W. Alt (Cambridge, MA); Yu Zhang (West Roxbury, MA); Roberto Chiarle (Brookline, MA); Monica Gostissa (Jamaica Plain, MA)
Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
C12Q1/6874C12Q1/6855C12Q1/6869G16B30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,508,304
App. No.
15/338,560
Granted
Dec 17, 2019
Kind
B2
Abstract

Provided are methods for high-throughput screening to determine locations of double-stranded DNA breaks (DSBs) and translocations in genomes caused by different agents, such as enzymes.

Claims (34)

1. A method for high throughput, genome-wide translocation sequencing (HTGTS) and identification of double-stranded DNA break (DSB) locations comprising the steps of:

a. exposing a cell to an agent known or suspected to be capable of producing a DSB;

b. optionally allowing the cell to divide for at least 12 hours;

c. extracting genomic DNA from the cells;

d. producing a fragmented DNA sample by fragmenting the DNA of the cell with a frequently cutting restriction enzyme;

e. producing a ligated DNA sample by ligating the fragmented DNA at a concentration favoring intra-molecular ligation, thereby providing circularized DNA fragments;

f. digesting the ligated DNA sample with a blocking restriction enzyme, wherein the blocking restriction enzyme is different than the restriction enzyme of step d), thereby providing:

i. circularized DNA fragments comprising translocations or DSBs; and

ii. linearized DNA fragments not comprising translocations or DSBs;

g. producing nested PCR products by performing a nested PCR with locus-specific primers on the products of step f.;

h. sequencing the nested PCR products; and

i. aligning the sequences against a reference sequence to identify chromosomal locations of the translocations or DSBs.

2. The method of claim 1 , further comprising a step of inserting into a cell to be analyzed at least one target sequence for the agent of step a., wherein the target sequence is known to be absent in the genome of the cell to be analyzed prior to step (a) of claim 1 .

3. The method of claim 1 , wherein the agent of step a. is a rare-cutting enzyme.

4. The method of claim 1 , wherein the agent of step a. is a meganuclease; a transcription activator-like effector nuclease, which is a sequence specific nucleases made by fusing a transcription activator like effector DNA-binding domain to a catalytic domain of an endonuclease; or a zinc-finger nuclease.

5. The method of claim 1 , wherein the cells are allowed to divide for 1-5 days.

6. The method of claim 5 , wherein the cells are allowed to divide for 2-4 days.

7. The method of claim 1 , wherein the step of aligning is performed by a machine.

8. The method of claim 7 , wherein the machine comprises a computer executable software.

9. The method of claim 8 further comprising a display module for displaying the results of the step of aligning.

10. The method of claim 1 , wherein the cell is a mammalian cell.

11. The method of claim 1 , wherein the cell is a plant cell.

12. The method of claim 1 , wherein the cell division step (b) is omitted.

13. A method for high throughput, genome-wide translocation sequencing (HTGTS) and identification of double-stranded DNA break (DSB) locations comprising the steps of:

a. exposing a cell to an agent known or suspected to be capable of producing a DSB wherein the agent is a meganuclease; a transcription activator-like effector nuclease, which is a sequence specific nucleases made by fusing a transcription activator like effector DNA-binding domain to a catalytic domain of an endonuclease; or a zinc-finger nuclease;

b. optionally allowing the cell to divide for at least 12 hours;

c. extracting genomic DNA from the cells;

d. producing a fragmented DNA sample by fragmenting the DNA of the cell with a frequently cutting restriction enzyme;

e. producing a ligated DNA sample by ligating the fragmented DNA at a concentration favoring intra-molecular ligation, thereby providing circularized DNA fragments;

f. digesting the ligated DNA sample with a blocking restriction enzyme, wherein the blocking restriction enzyme is different than the restriction enzyme of step d), thereby providing:

i. circularized DNA fragments comprising translocations or DSBs;

g. producing nested PCR products by performing a nested PCR with locus-specific primers on the products of step f.;

h. sequencing the nested PCR products; and

i. aligning the sequences against a reference sequence to identify chromosomal locations of the translocations or DSBs.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2017
From: ALT, FREDERICK W.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 042195/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2017
From: HOWARD HUGHES MEDICAL INSTITUTE
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 042195/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2017
From: ZHANG, YU; CHIARLE, ROBERTO; GOTISSA, MONICA
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 042195/0338 →
Continuity (3)
Division 14131236
Provisional Application 61505374 · Jul 7, 2011
Related Publication 20170044607A1 · Feb 16, 2017